Key Highlights The Alpha Thalassemia Market is projected to grow at a significant CAGR by 2036 in leading countries (US, EU4, UK and Japan). The leading Alpha Thalassemia Companies, such as Agios Pharmaceuticals, Forma Therapeutics, Silence Therapeutics, and others. Alpha Thalassemia Market and Epid ...

Key Highlights The total number of NSCLC Incidence Cases of in the 7MM was nearly 526,800 in 2022 and is projected to increase during the forecasted period. Only one product is available for the BRAF-mutated NSCLC patient pool: TAFINLAR (dabrafenib) in combination with MEKINIST (trametinib). In June ...

Key Highlights The HER2+ NSCLC Market (Mutant, Overexpression, and Amplification) in the 7MM was USD ~850 million in 2023 and is expected to increase to USD ~3,110 million by 2036, at a CAGR of 13.2%. NSCLC comprises approximately 80– 85% of all lung cancer diagnoses, with HER2+ gene mutation found ...

Key Highlights The total market size in the 7MM for Hodgkin lymphoma is expected to grow with a significant CAGR during the forecast period (2026-2036). In 2023, the US accounted for the maximum share of the total market in the 7MM. In 2024, an estimated 8,570 (4,630 in males and 3,940 in females) n ...

Key Highlights The Castration-sensitive Prostate Cancer Market in the 7MM was valued at approximately USD 5,143 million in 2025 over the forecast period from 2026 to 2036. The Castration-sensitive Prostate Cancer Market is projected to grow at a CAGR of 10% by 2036 in the leading countries (the US, ...

Key Highlights The Follicular Lymphoma Market Size in the 7MM is expected to grow from USD 1,702 million in 2025 to USD 3,081 million in 2036. The Follicular Lymphoma Market is projected to grow at a CAGR of 6.8% by 2036 in leading countries like the US, EU4, UK, and Japan. Follicular Lymphoma Marke ...

Key Highlights Bardet-Biedl syndrome (BBS) is a rare autosomal recessive ciliopathy. The disease mapped to at least twenty different genes (BBS1-BBS20), follow oligogenic inheritance pattern. Bardet-Biedl syndrome (BBS) is also known by several other names, including: Laurence–Moon–Biedl–Bardet synd ...

Key Highlights Based on DelveInsight’s evaluation, the asthma market size across the 7MM was estimated at around USD 27 billion in 2024 and is expected to expand at a CAGR of 1.9% from 2026 to 2036. The Asthma companies developing therapies in the treatment landscape include - Sanofi, Regeneron Phar ...

Key Highlights Breast Cancer is the second most common cancer in women and men worldwide, and among all types of Breast Cancer, estrogen receptor-positive (ER+) Breast Cancer is the most common type of cancer diagnosed in patients with Breast Cancer. The total incident population of Breast Cancer in ...

Key Highlights The Drug-Resistant Epilepsy Market is expected to strengthen as awareness of the disease increases, and more effective interventions are being developed. The leading Drug-Resistant Epilepsy Companies, such as LivaNova, Neurona Therapeutics, IAMA Therapeutics, and others. Drug-Resistan ...